Neuromonitoring mittels S100B-Protein: Stellenwert für die Neonatologie, pädiatrische Intensivmedizin und Pädiatrie

Zusammenfassung

In den letzten Jahren hat die Bestimmung biochemischer Marker (S100B-Protein, Neuronen-spezifische Enolase) zur Prognoseabschätzung nach zerebraler Ischämie und Schädel-Hirn-Trauma zunehmend Eingang in die Klinik gefunden. In der Pädiatrie spielt die Bestimmung von S100B-Protein insbesondere bei Neugeborenen nach perinataler Asphyxie sowie bei Kindern nach Schädel-Hirn-Trauma eine Rolle. Ziel dieser Arbeit ist es, einen Überblick über die klinische Bedeutung von S100B-Protein insbesondere für das Neuromonitoring nach nicht-traumatischen und traumatischen Schädigungen des Gehirns bei Neugeborenen und älteren Kindern zu geben.

Abstract

During the last years neuromonitoring with various biochemical markers such as S100B protein has been introduced into the clinical settings of neonatal and pediatric intensive care. Several investigations have been undertaken to correlate S100B protein concentrations to the diagnosis and prognosis of neonates and children with severe cerebral disorders. This articles gives a review on the current knowledge, indications and limitations on the use of S100B protein after non-traumatic and traumatic brain injury in neonates and children.

S100B-Protein - Neuromonitoring - perinatale Asphyxie - Schädel-Hirn-Trauma - Prognose - Kinder

S100B protein - neuromonitoring - asphyxia - brain injury - outcome - children

Literatur

• 1 Akhtar J I, Spear R M, Senac M O, Peterson B M, Diaz S M. Determination of traumatic brain injury with magnetic resonance imaging and S-100B protein in children, despite normal computed tomography of the brain.  Pediatr Crit Care Med. 2003;  4 322-326
• 2 Anderson R E, Hansson L O, Liska J, Settergren G, Vaage J. The effect of cardiotomy suction on the brain injury marker S100B after cardiopulmonary bypass.  Ann Thorac Surg. 2000;  69 847-850
• 3 Anderson R E, Hansson L O, Nilsson O, Liska J, Settergren G, Vaage J. Increase in serum A1000A1-B and S100BB during cardiac surgery arises from extracerebral sources.  Ann Thorac Surg. 2001;  71 1512-1517
• 4 Beems T, Simons K S, van Geel W JA, de Reus H PM, Vos P E, Verbeck M M. Serum- and CSF-concentrations of brain-specific proteins in hydrocephalus.  Acta Neurochir. 2003;  145 37-43
• 5 Berger R. Biomarkers or neuroimaging in central nervous system injury: Will the real “gold standard” please stand up?.  Pediatr Crit Care Med. 2003;  4 391
• 6 Berger R P, Pierce M C, Wisnieski S R, Adelson P D, Kochanek P. Serum S100B concentrations are increased after closed head injury in children: a preliminary study.  J Neurotrauma. 2002;  19 1404-1409
• 7 Berger R P, Pierce M C, Wisniewski S R, Adelson P D, Clark R SB, Ruppel R A, Kochanek P M. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.  Pediatrics. 2002;  109 e31
• 8 Blennow M, Savman K, Ilves P, Thoresen M, Rosengren L. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants.  Acta Paediatr. 2001;  90 1171-1175
• 9 Buonocore G, Perrone S. Biomarkers of hypoxic brain injury in the neonate.  Clin Perinatol. 2004;  31 107-116
• 10 de Vries J, Thijssen W AM, Snels S EA, Menovsky T, Peer N GM, Lamres K JB. Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients.  J Neurol Neurosurg Psychiatry. 2001;  71 671-674
• 11 Dennery P A. Predicting neonatal brain injury. Are we there yet?.  Arch Pediatr Adolesc Med. 2003;  157 1151-1152
• 12 Donato R. S-100 proteins.  Cell Calcium. 1986;  7 123-145
• 13 Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles.  Int J Biochem Cell Biol. 2001;  33 637-668
• 14 Gazzolo D, Michetti F, Bruschettini M, Marchese N, Lituania M, Mangraviti S, Pedrazzi E, Bruschettini P. Pediatric concentrations of S100B protein in blood: Age- and sex-related changes.  Clin Chem. 2003;  49 967-970
• 15 Gazzolo D, Di Iorio R, Marinoni E, Masetti P, Serra G, Giovanni L, Michetti F. S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage.  Crit Care Med. 2002;  30 1356-1360
• 16 Gazzolo D, Marinoni E, Di Ioria R, Bruschettini M, Kornacka M, Lituania M, Majewska U, Serra G, Michetti F. Urinary S100B protein measurements: A tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants.  Crit Care Med. 2004;  32 131-136
• 17 Gazzolo D, Vinesi P, Bartocci M, Geloso M C, Bonacci W, Serra G, Haglid K G, Michetti F. S100 blood level as early indicators of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry.  J Neurol Sci. 1999;  170 32-35
• 18 Gazzolo D, Marioni E, Di Iorio R, Lituania M, Bruschettini P L, Michetti F. Circulating S100B protein is increased in intrauterine growth retarded fetuses.  Pediatr Res. 2002;  51 215-219
• 19 Gazzolo D, Bruschettini M, Corvino V, Oliva R, Sarli R, Lituania M, Bruschetini P, Michetti F. S100B protein concentrations in amniotic fluid are correlated with gestational age and with cerebral ultrasound scanning parameters results in healthy fetuses.  Clin Chem. 2001;  47 954-956
• 20 Hermann M, Ehrenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring.  Restor Neurol Neurosci. 2003;  21 177-190
• 21 Howard A, Legon S, Spurr N K, Walters J RF. Molecular cloning and chromosome assignment of human calbindin-D9K.  Biochem Biophys Res Commun. 1992;  185 663-669
• 22 Infante J R, Martinez A, Ochoa J, Canadillas F, Torres-Avisbal M, Vallejo J A, Gonzalez F M, Pacheco C, Latre J M. Cerebrospinal fluid S-100 protein levels in neurological pathologies.  J Physiol Biochem. 2003;  59 255-261
• 23 Infante J R, Torres-Avisbal M, Martinez A, Vallejo J A, Aguilera C, Contreras P, Benitez A, Latre J M. Evaluation of tumor marker S-100 in cerebrospinal fluid from subjects with non-ischemic brain pathologies.  Tumor Biology. 2000;  21 38-45
• 24 Ingebrigtsen T, Romner S, Marup-Jensen S, Dons M, Lundquist C, Alling C, Borgesen S E. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study.  Brain Inj. 2000;  14 1047-1055
• 25 Ingebrigsten T, Waterloo K, Jacobson E A, Langbakk B, Romner B. Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome.  Neurosurgery. 1999;  45 468-475
• 26 Ingebrigtsen T, Romner B. Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury.  Restor Neurol Neurosci. 2003;  21 171-176
• 27 Isobe T, Ishioka N, Okuyama T. The amino-acid sequence of the α subunit in bovine brain S-100 protein.  Eur J Biochem. 1981;  116 79-86
• 28 Isobe T, Okuyama T. Structural relation of two S-100 proteins in bovine brain; subunit composition of S-100-a protein.  Eur J Biochem. 1981;  115 469-474
• 29 Isobe T, Okuyama T. The amino-acid sequence of S-100 protein (PAP I-b) and its relationship to calcium-binding proteins.  Eur J Biochem. 1978;  89 379-388
• 30 Jensen E, Sandstrom K, Andreasson S, Nilsson K, Berggren H, Larsson L E. Increased levels of S-100 protein after cardiac surgery with cardiopulmonary bypass and general surgery in children.  Paediatr Anaesth. 2000;  10 297-302
• 31 Lamers K J, Vos P, Verbeek M M, Rosmalen F, van Geel W J, Engelen B G van. Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients.  Brain Res Bull. 2003;  15 261-264
• 32 Lardner D, Davidson A, McKenzie I, Cochrane A. Delayed rise in serum S100B levels and adverse neurological outcome in infants and children undergoing cardiopulmonary bypass.  Paediatr Anaesth. 2004;  14 495-500
• 33 Leviton A, Dammann O. Brain damage markers in children. Neurobiological and clinical aspects.  Acta Paediatr. 2002;  91 9-13
• 34 Marchi N, Rasmussen P, Kapural M, Fazio V, Kight K, Mayberg M, Kanner A, Ayumar B, Albensi B, Cavaglia M, Janigro D. Peripheral markers of brain damage and blood-brain-barrier dysfunction.  Restor Neurol Neurosc. 2003;  21 109-121
• 35 Marks A, Allore R J. S-100 protein and Down syndrome.  Bioessays. 1990;  12 381-383
• 36 McAdory B S, Eldik L J Van, Norden J J. S100B, a neurotrophic protein that modulates neuronal protein phosphorylation, is up-regulated during lesion-induced collateral sprouting and reactive synaptogenesis.  Brain Res. 1998;  813 211-217
• 37 Michetti F, Gazzolo D. S100B protein in biological fluids: A tool for perinatal medicine?.  Clin Chem. 2002;  48 2097-2014
• 38 Moore B W. A soluble protein characteristic of the nervous system.  Biochem Biophys Res Commun. 1965;  19 739-743
• 39 Nagdyman N, Grimmer I, Scholz T, Müller M, Obladen M. Predictive value of brain-specific proteins in serum or neurodevelopmental outcome after birth asphyxia.  Pediatr Res. 2003;  54 270-275
• 40 Nagdyman N, Kömen W, KO H K, Müller C, Obladen M. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia.  Pediatr Res. 2001;  49 502-506
• 41 Ozatik M A, Tarcan O, Kale A, Askin G A, Balci M, Undar A, Kucukaksu D S, Sener E, Tasdemir O. Do S100beta protein level increases due to inflammation due to cardiopulmonary bypass occur without any neurological deficits?.  Perfusion. 2002;  17 335-338
• 42 Park E S, Park C I, Baek S Y, Kim S W, Baek S K, Kim H O. Serum immunoreactivity to S-100 in children with cerebral palsy and delayed development and in their healthy parents.  Yonsei Med J. 2000;  41 328-332
• 43 Park E S, Park C I, Choi K S, Choi I H, Shin J S. Over-expression of S100B protein in children with cerebral palsy or delayed development.  Brain Dev. 2004;  26 190-196
• 44 Portela L VC, Tort A BL, Schaf D V, Ribeiro L, Nora D B, Walz R, Rotta L N, Silva C T, Busnello J V, Kapczinski F, Goncalves C A, Souza D O. The serum S100B concentration is age-dependent.  Clin Chem. 2002;  48 950-952
• 45 Romner B, Ingebrigsten T, Kongstad P, Borgesen S E. Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings.  J Neurotrauma. 2000;  17 641-647
• 46 Schulpis K H, Kariyannis C, Papassotiriou I. Serum levels of neural protein S-100B in phenylketonuria.  Clin Biochem. 2004;  37 76-79
• 47 Shaaban A M, Harmer M, Elliot M, Thomas A L, Kirkham F. A pilot study of evaluation of cerebral function by S100beta protein and near-infrared spectroscopy during cold and warm cardiopulmonary bypass in infants and children undergoing open-heart surgery.  Anaesthesia. 2004;  59 20-26
• 48 Shaaban A M, Harmer M, Vaughan R. Serum S100 protein as a marker of cerebral damage during cardiac surgery.  Brit J Anaesth. 2000;  85 287-298
• 49 Spinella P C, Dominguez T, Drott H E, Huh J, McCormick L, Rajendra A, Argon J, McIntosh T, Helfaer M. S-100beta protein serum levels in healthy children and its association with outcome in pediatric traumatic brain injury.  Crit Care Med. 2003;  31 939-945
• 50 Spinella P C, Donoghue A, Rajendra A, Drott H R, Dominguez T E, Helfaer M. Cerebrospinal fluid levels of S-100beta in children and its elevation in pediatric meningitis.  Pediatr Crit Care. 2004;  5 53-57
• 51 Synder-Ramos S A, Bottiger B W. Molecular markers of brain damage - clinical and ethical implications with particular focus on cardiac arrest.  Restor Neurol Neurosci. 2003;  21 123-139
• 52 Synder-Ramos S A, Gruhlke T, Bauer T, Bauer M, Luntz A P, Motsch J, Martin E, Vahl C F, Missler U, Wiesmann M, Böttiger B W. Cerebral and extracerebral release of protein S100B in cardiac surgical patients.  Anaesthesia. 2004;  59 344-349
• 53 Unertl K, Kottler M. Prognostische Scores in der Intensivmedizin.  Anaesthesist. 1997;  46 471-480
• 54 van Passel R, Schlooz W A, Lamers K J, Lemmens W A, Rotteveel J J. S100b protein, glia and Gilles de la Tourette syndrome.  Eur J Paediatr Neurol. 2001;  5 15-19
• 55 Wainwright M S, Craft J M, Griffin W S, Marks A, Pineda J, Padgett K, Eldik J Van. Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia.  Ann Neurol. 2004;  56 61-67
• 56 Whitelaw A, Rosengren L, Blennow M. Brain specific proteins in posthaemorrhagic ventricular dilatation.  Arch Dis Child (Fetal and Neonatal Ed). 2001;  84 F90-F91
• 57 Woertgen C, Rothoerl R D, Holzschuh M Metz C, Brawanski A. Comparison of serial S-100 and NSE serum measurements after severe head injury.  Acta Neurochir. 1997;  139 1161-1164
• 58 Woertgen C, Rothoerl R D, Metz C, Brawanski A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury.  J Trauma. 1999;  47 1126-1130
• 59 Wunderlich M T, Ebert A D, Kratz T, Goertler M, Jost S, Hermann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage.  Stroke. 1999;  30 1190-1195
• 60 Zimmer D B, Cornwall E H, Landar A, Song W. The S100 protein family: history, function, and expression.  Brain Res Bull. 1995;  37 417-429